SARS-CoV-2 has rapidly spread across the globe and infected hundreds of millions of
people worldwide. As our experience with this virus continues to grow, our understanding of …

Children and adolescents infected with severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) are predominantly asymptomatic or have mild symptoms compared with the …

Background Data on the long-term impact of SARS-CoV-2 infection in children and young
people (CYP) are conflicting. We assessed evidence on long-term post-COVID symptoms in …

Multisystem inflammatory syndrome in children (MIS-C) is a rare and severe condition that
follows benign COVID-19. We report autosomal recessive deficiencies of OAS1, OAS2, or …

Multisystem inflammatory syndrome in children (MIS-C) emerged in April 2020 in
communities with high COVID-19 rates. This new condition is heterogenous but resembles …

In rare instances, pediatric SARS-CoV-2 infection results in a novel immunodysregulation
syndrome termed multisystem inflammatory syndrome in children (MIS-C). We compared …

During the coronavirus disease 2019 (COVID-19) pandemic, social isolation, semi-
lockdown, and “stay at home” orders were imposed upon the population in the interest of …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection became a
pandemic in 2020 and by March 2022 had caused more than 479 million infections and 6 …

Abstract Purpose of Review To review the spectrum of cardiac manifestations and
treatments of multisystem inflammatory syndrome in children (MIS-C) associated with …

Purpose of Review A multisystem inflammatory condition occurring in children and
adolescents with COVID-19 has become increasingly recognized and widely studied …